Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Critique
Editorial
Errata
Erratum
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Research Correspondence
Retraction
Review Article
Short Paper
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Critique
Editorial
Errata
Erratum
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Research Correspondence
Retraction
Review Article
Short Paper
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
View/Download PDF

Translate this page into:

Original Article
154 (
1
); 108-114
doi:
10.4103/ijmr.IJMR_1208_18

Distribution of APOE gene polymorphism in the Chinese Uyghur children & its association with urolithiasis

Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China
Present address: Department of Preventive Medicine, Shenzhen Pingle Orthopedics Hospital (Shenzhen Pingshan Hospital of Traditional Chinese Medicine), Shenzhen, 518122, Guangdong Province, China

For correspondence: Dr Kusheng Wu, Department of Preventive Medicine, Shantou University Medical College, No. 22, Xinling Rd., Shantou 515041, Guangdong, PR China e-mail: kswu@stu.edu.cn

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Background & objectives:

This study was to survey the apolipoprotein E (APOE) gene polymorphism distribution among Chinese Uyghur children and to explore the relationship between APOE gene polymorphism and the occurrence of urolithiasis.

Methods:

A total of 144 Uyghur children with urolithiasis and 274 without the history of urolithiasis were enrolled in this study. Venous blood samples were collected from all participants, and APOE genotyping, derived from rs429358 and rs7412, was performed using Sanger sequencing.

Results:

Among the 418 children, the most prevalent genotype was E3/3, accounting for 71.3 per cent in the urolithiasis group and 71.4 per cent in the control group, followed by E3/4 and E2/3. Higher frequencies of the ɛ2 and ɛ4 alleles and lower frequencies of the ɛ3 allele were observed in the test group, and the unusual allele ɛ1 was also found in them. However, there were no significant differences between cases and controls at both rs429358 and rs7412 genotype and allele frequencies [odds ratio (OR)=0.98, 95% confidence interval (CI): 0.57-1.67; 0.98 (0.59-1.63); 1.43 (0.75-2.74) and 1.40 (0.74-2.62), respectively]. Likewise, none of significant differences was found between cases and controls at both APOE genotype and allele frequencies [OR=0.88, 95% CI: 0.51-1.53; 0.74 (0.33-1.64); 1.10 (0.73-1.66); 1.13 (0.76-1.67) and 1.14 (0.76-1.70), respectively].

Interpretation & conclusions:

The present study does not support any association between APOE genotyping and urolithiasis in Uyghur children.

Keywords

Apolipoprotein E
gene polymorphism
urolithiasis
Uyghur children

There are various reports of a globally increasing incidence of urolithiasis, of which 2-3 per cent is represented by the paediatric population12. There is considerable cause for public concern because urolithiasis is associated with to significant pain, decreased renal function and increased costs34. Clinical data have documented the youngest patient with urolithiasis as a three-month-old Uygur child from Xinjiang, China5. Literature suggests that the younger the patient is, the higher the recurrence rate will be, with about 50 per cent of children presenting with recurrent symptomatic urolithiasis within three years after the initial treatment. Once urolithiasis has recurred, the recurrence frequency is suggestively increased significantly and recurrence interval is also shortened678.

Urolithiasis is a complex polygenic, multifactorial disease where genetic and environmental factors together significantly contribute to the pathophysiology and pathogenesis of urolithiasis9. Epidemiological investigations have suggested environmental factors, such as climate, lifestyle and dietary habits, influence the development of urolithiasis101112. Nevertheless, with the development of molecular biology and the in-depth analysis of urinary calculi, genetic factors have started receiving increased attention over the year, also the study of single-nucleotide polymorphisms (SNPs) has emerged as a tool to identify the association of genes with various diseases and to prevent diseases1314. Previously published studies have shown the association of some genes such as those encoding lipoproteins, [paraoxonase-1 and apolipoprotein E (APOE)], with urolithiasis1516.

The APOE gene is polymorphic, resulting from two amino acid substitutions, cysteine (Cys) and arginine (Arg) at positions 112 (rs429358) and 158 (rs7412)1718. The APOE gene is located on the chromosome 19q13 and possesses three alleles in general, designated ɛ2, ɛ3 and, ɛ4, which vary in the presence of either C or T nucleotides at positions 112 and 15817181920. Of these, the allele ɛ3 is the most prevalent and the rare allele ɛ1 presents only in special populations21. The three alleles encode three common isoforms, namely E2 (Cys112/Cys158), E3 (Cys112/Arg158) and E4 (Arg112/Arg158), giving rise to six different genotypes three homozygous (E2/E2, E3/E3 and E4/E4) and three heterozygous (E2/E3, E2/E4 and E3/E4)17182022. Although there are only one or two amino acid changes, APOE variants transform APOE structure and function23. Likewise, the distribution of APOE polymorphism varies in different populations and ethnics groups202223.

A study on Uyghur adults demonstrated that urolithiasis was associated with APOE gene polymorphism, and the E3/4 genotype and ɛ4 allele might be susceptibility factors for this condition16. However, little is known about the relationship between the APOE gene polymorphism and Uyghur children urolithiasis and, the main influencing factors for children urolithiasis may differ from those of adult urolithiasis. Thus, there is a clear need for studies exploring the distribution of APOE gene polymorphism in the Chinese Uyghur children and risk of urolithiasis in them.

Material & Methods

Subjects: A total of 418 Uyghur children under 14 yr of age from the First People’s Hospital of Kashi, Xinjiang Uyghur Autonomous Region, People’s Republic of China, were included in the study between April 2016 and February 2017, comprising 144 cases (109 males) and 274 controls (175 males).

Inclusion criteria for the cases were defined as follows: (i) Uyghur children under the age of 14 yr; (ii) outpatients and inpatients with a diagnosis of urolithiasis; (iii) urolithiasis was confirmed by ultrasound, abdominal X-ray or computerized tomography (CT); (iv) no other chronic renal failure or chronic urinary infection diseases and; (v) no other metabolic diseases. Inclusion criteria for the controls were defined as follows: (i) Uyghur children under the age of 14 yr; (ii) coming from the same region as the cases; (iii) no history of urolithiasis; (iv) no chronic renal failure or chronic urinary tract infections; and (v) no other metabolic diseases. The study was approved by the Ethics Committee of Shantou University Medical College Shantou, China, and written informed consent was obtained from the children’s parents or guardians of the children.

Parameters studied: Basic demographic information (age, gender, height and weight) and some clinical mineral profiles [serum potassium (K), sodium (Na), chlorine (Cl), calcium (Ca), phosphate (P) and magnesium (Mg)] were collected from medical records.

DNA isolation and apolipoprotein E genotyping: Two millilitres of venous blood was collected in anticoagulant tubes, and DNA was extracted using blood genomic DNA extraction kit (Tiangen Biotech Co., Ltd., Beijing, China) as per manufacturer’s protocol. The purity and concentration of extracted DNA were determined by NanoDrop 2000 Ultramicro Spectrophotometer (Thermo Scientific, USA), and the quality was identified by agarose gel electrophoresis.

Polymerase chain reaction (PCR) amplification for APOE genotyping was performed using an optimization method of a high guanine–cytosine (GC) fragment2425. The primers were synthesized BGI Tech Co. Ltd. Shenzhen, China, and referring to the related literature, their sequences were as follows25 forward: 5’-AACAACTGACCCCGGTGGCG-3’ and reverse: 5’-ATGGCGCTGAGGCCGCGCTC-3’. A total of 25 µL PCR mixture contained 12.5 uL 2×premix Taq™ (Takara Bio, Inc., Tokyo, Japan), 0.5 µL forward and reverse primer each (10 µmol/µL), 1 µL DNA template, 2.5 µL dimethyl sulfoxide and 8.5 µL ddH2O. PCR amplification was performed in a thermal cycler (Bio-Rad, California, USA), and cycling parameters were set as follows: 95°C denaturation for five minutes, and first five cycles (95°C for one minute and 72°C for three minutes), and then 30 cycles (95°C for one minute, 65°C for one minute, and 72°C for one minute), and finally extension at 72°C for 10 min. After amplification, the PCR products of 292 bp were identified by 2.0 per cent agarose gel electrophoresis, and APOE genotyping was performed (BGI Tech, Shenzhen, China) by Sanger sequencing.

Statistical analysis: The genotype distributions of two SNPs (rs429358 and rs7412) were analyzed using Chromas and MegAlign, and APOE genotypes were assigned derived from the genotype distribution of the two SNPs202627 (Table I). The APOE alleles were defined as follows202627: ɛ1=rs429358(C)+rs7412(T), ɛ2 =rs429358(T) +rs7412(T), ɛ3=rs429358(T)+rs7412(C) and ɛ4=rs429358(C)+rs7412(C). Hardy–Weinberg equilibrium (HWE) of two SNPs (rs429358 and rs7412) was evaluated using online encyclopaedia for Genetic Epidemiology studies (OEGE) software ((http://www.oege.org/software/hardy-weinberg.html)28.

Table I Apolipoprotein E (APOE) genotype distribution based on two single-nucleotide polymorphisms (rs429358 and rs7412)
rs429358 rs7412 APOE
C/C C/C E4/4
T/C C/C E3/4
T/T C/C E3/3
T/T T/C E2/3
T/C T/C E2/4
T/T T/T E2/2

Continuous data were presented as mean ± standard deviations and categorical data as numbers (percentages). Normal distribution of data was assessed by Kolmogorov–Smirnov and Shapiro–Wilk tests. For comparing basic demographic characteristics and mineral profiles, an independent sample t test was used for continuous variables normally distributed, and otherwise, Mann–Whitney U test was used. Chi-square test was used for categorical variables. All genotype and allele frequency distributions were analyzed with Chi-square test, and unconditional binary logistic regression was used for odds ratios (ORs) and confidence intervals (CIs). All analyses were conducted using IBM SPSS 22.0 software (IBM, Armonk, NK, USA), and two-sided P<0.05 was defined as statistical significance.

Results

Characteristics of the participants: The summary statistics of demographic characteristics and mineral profiles between the urolithiasis group (n=144) and the control group (n=274) are described in Table II. There was no statistical difference in the mean age between the urolithiasis and the control group; the mean body mass index was also not different between these two groups, but there were more boys in the urolithiasis group. As for mineral profiles, serum Cl and Ca levels were higher for children with urolithiasis, but serum Mg level was lower for children with urolithiasis. Levels for serum K, Na and P were not found to be different in either group.

Table II Comparison of demographic characteristics and mineral profiles between the case and control groups (SD)
Parameters Case group (n=144) Control group (n=274) P
Age (yr) 4.48±3.19 4.55±3.57 0.661
Gender, n (%)
Male 109 (75.7) 175 (63.9) 0.014
Female 35 (24.3) 99 (36.1)
BMI, kg/m2 17.54±6.84 18.56±8.16 0.515
Serum K, mmol/L 4.43±0.60 4.21±0.77 0.725
Serum Na, mmol/L 138.49±3.86 137.59±5.55 0.130
Serum Cl, mmol/L 105.08±4.48 103.67±6.42 0.031
Serum Ca, mmol/L 2.32±0.13 2.29±0.20 0.020
Serum P, mmol/L 1.70±0.36 1.68±0.43 0.645
Serum Mg, mmol/L 0.86±0.10 0.90±0.15 0.003

Data are presented as mean±SD unless indicated. SD, standard deviation; BMI, body mass index; K, potassium; Na, sodium; Cl, chlorine; Ca, calcium; P, phosphate; Mg, magnesium

Apolipoprotein E (APOE) rs429358 and rs7412 gene polymorphisms: The genotyping results of APOE rs429358 and rs7412 are shown in Figure, and the summary statistics of two-SNP genotype and allele frequency distributions are presented in Table III. The genotype frequency distributions of the two SNPs were consistent with the Hardy-Weinberg equilibrium (HWE) in both the case and control groups. Only within the control group, five children were detected with rs429358 CC genotype and one child with the rs7412 TT genotype in this study. Thus, during subsequent analysis, individuals with the rs429358 CC genotype or the rs7412 TT genotype were excluded. However, there was neither any statistical difference between cases and controls with rs429358 and rs7412 genotypes, nor in allele frequencies [OR=0.98, 95% CI: 0.57-1.67; 0.98 (0.59-1.63); 1.43 (0.75-2.74) and 1.40 (0.74-2.62), respectively].

The sequencing map of APOE rs429358 and rs7412, the arrows indicate the mutation s namely, A: rs429358 TT; B: rs7412 CC; C: rs429358 TC; D: rs7412 CT; E: rs429358 CC; F: rs7412 TT.
Figure
The sequencing map of APOE rs429358 and rs7412, the arrows indicate the mutation s namely, A: rs429358 TT; B: rs7412 CC; C: rs429358 TC; D: rs7412 CT; E: rs429358 CC; F: rs7412 TT.
Table III Associations of rs429358 and rs7412 gene polymorphisms with children urolithiasis
APOE gene polymorphisms Patient group n (%) Control group n (%) OR (95%CI)
rs429358a
TT 111 (81.6) 218 (82.0) 0.98 (0.57-1.67)
TC 25 (18.4) 48 (18.0) 1.00
T 247 (90.8) 484 (91.0) 0.98 (0.59-1.63)
C 25 (9.2) 48 (9.0) 1.00
rs7412b
CC 122 (89.7) 232 (85.9) 1.43 (0.75-2.74)
CT 14 (10.3) 38 (14.1) 1.00
C 258 (94.9) 502 (93.0) 1.40 (0.74-2.62)
T 14 (5.1) 38 (7.0) 1.00

aIndividuals (n=5) with CC genotype in the control group were excluded from the analysis; bIndividual (n=1) with TT genotype in the control group was excluded from the analysis. OR, odds ratio; CI, confidence interval

APOE gene polymorphism: APOE polymorphism derived from rs429358 and rs7412 is presented in Table IV. In theory, six genotypes can be generated based on both SNPs (rs429358 and rs7412)17182022. However, three common genotypes in the children, namely E3/4, E3/3 and E2/3, were identified in our study. Only in the control group, five, six and one children were identified with E4/4, E2/4 and E2/2 genotypes, respectively. Therefore, individuals with the E4/4, E2/4 or E2/2 genotype were removed from the subsequent analysis. For most human populations, three common APOE alleles (ɛ2, ɛ3 and ɛ4) can be detected17181920. In the present study, the unusual allele ɛ1 was also detected. As shown in Table IV, both cases and controls showed the highest frequencies for E3/3 genotype (71.3 and 71.4%) and ɛ3 allele (46.4 and 46.0%). However, none of the significant differences was found between cases and controls at both APOE genotype and allele frequencies [OR=0.88, 95% CI: 0.51-1.53; 0.74 (0.33-1.64); 1.10 (0.73-1.66); 1.13 (0.76-1.67) and 1.14 (0.76-1.70), respectively].

Table IV Association of apolipoprotein E gene polymorphism with children urolithiasis
APOE gene polymorphisms Patient group (n=136) n (%) Control group (n=259) n (%) OR (95% CI)
Genotype
E3/4 (ɛ4 carriera) 25 (18.4) 42 (16.2) 1.00
E3/3 97 (71.3) 185 (71.4) 0.88 (0.51-1.53)
E2/3 (ɛ2 carriera) 14 (10.3) 32 (12.4) 0.74 (0.33-1.64)
Allele
ɛ1 39 (3.6) 86 (4.0) 1.00
ɛ2 261 (24.0) 522 (24.3) 1.10 (0.73-1.66)
ɛ3 505 (46.4) 986 (46.0) 1.13 (0.76-1.67)
ɛ4 283 (26.0) 550 (25.7) 1.14 (0.76-1.70)

aIndividuals (n=5, 6, 1) with the E4/4, E2/4 and E2/2 genotype in the control group were removed from our analysis, respectively. OR, odds ratio; CI, confidence interval

Discussion

In the present study, for APOE genotype distribution derived from both SNPs (rs429358 and rs7412), six genotypes, namely E3/4, E3/3, E2/3, E4/4, E2/4 and E2/2 were found. E3/3 was observed as the predominant genotype, found in 71.3 per cent in the urolithiasis group and 71.4 per cent in the control group. In case of APOE allele distribution, three common alleles, namely ɛ2, ɛ3 and ɛ4, and the rare allele ɛ1 were observed.

Among all participants, the most prevalent genotype was E3/3, followed by E3/4 and E2/3, which is in accordance with the results of Han Chinese population living in other areas2229. Furthermore, a comparison of APOE genotype frequencies in nine populations (Tyrolean, Sudanese, Indian, Chinese, Japanese, Hungarian, Icelandic, Finnish and Malay) has suggested the major APOE genotypes as E2/3 (frequency range: 7.0 to 16.9%), E3/3 (frequency range: 39.8 to 72.1%) and E3/4 (frequency range: 11.3 to 35.9%)30. The results of the present study were within this frequency range. However, previous published studies on Uygur men in Xinjiang, China, have shown that in addition to E3/3, E3/4, and E3/3 genotypes, E4/4 genotypes also have a high frequency2331. Our results showed some differences, possibly due to a different population set and a different history of disease.

Interestingly, compared with the studies of Han Chinese populations in the north and southwest2229, higher frequencies of the ɛ2 and ɛ4 alleles and lower frequencies of the ɛ3 allele were found in the present study. Archaeological and DNA sequencing researches have suggested that Uyghur was a unique ethnic group, originating from Europe, currently living in the Tarim Basin of Xinjiang region, China, and ethnically assimilated and integrated with the Han population for a long time3233. The present finding can provide additional evidence that Uyghurs are unique. Another study of correlation between APOE polymorphisms and urolithiasis in the Uyghur population has also reported similar finding16. Besides, the literatures suggests that ɛ2 and ɛ4 alleles were more frequent in Afro-Caribbeans and African-Americans compared with Caucasians and Asians.

The present study also found an unusual allele ɛ1. The rare ɛ1, inherited as a recessive, is mainly found in Caucasian populations2125. Based on archaeological finds, the Uyghur population suggestively belonged to the Caucasian race3233. Previous studies demonstrated ɛ3 was designated as wild type and its mutants were designated ɛ1 (Gly127 →Asp, Arg158→Cys), ɛ2 (Arg158→Cys) and ɛ4 (Cys112→Arg)2536. Further functional research found ɛ4 allele was associated with elevated low-density lipoprotein (LDL) level while ɛ1 allele was associated with decreased LDL level similar to the ɛ2 allele21. The functional analysis of these alleles indicated that there was no difference between the alleles ɛ1 and ɛ2 (Arg158→Cys), and the glycine/aspartic acid interchange at residue 127 may not be of functional significance2136. Therefore, particular attention should be paid to the pathological impact of the ɛ1 allele and the individuals who carry the ɛ2 and ɛ4 mutants at higher frequency than the wild allele ɛ3.

However, the present study does not support any association between APOE genotyping and urolithiasis in Uyghur children. In contrast, a similar study of Uyghur adults suggested urolithiasis was related to APOE gene polymorphism and the E3/4 genotype, and ɛ4 allele might be potential risk factors for urolithiasis16. This inconsistency in findings may be due to the difference in sample selection. Besides, some mineral profiles (such as serum Cl, Ca and Mg) were found to differ in both the groups, which indicate that occurrence of urolithiasis may be associated with mineral metabolism in the body.

There are, however, some limitations in the present study. Firstly, the blood lipid profiles of Uyghur children were not measured, so further analysis of the association of blood lipid levels with APOE gene polymorphism in order to perform a deep exploration of the risk factors of urolithiasis susceptibility could not be achieved. Second, compared with the number of adult urolithiasis cases, the sample size in the present study was relatively small.

Overall, the APOE genotype and allele frequency distributions in Uyghur children are unique compared with Han Chinese and Caucasian populations. However, the present study does not support any association between APOE genotypes and urolithiasis in Uyghur children.

Acknowledgment:

Authors thank medical workers from the First People’s Hospital of Kashi for their sample collection.

Financial support & sponsorship: The study was supported by the Natural Science Foundation of Guangdong Province (No. 2014A030313474).

Conflicts of Interest: None.

References

  1. , , . Pediatric kidney stones:Long-term outcomes. Urology. 2006;67:812-6.
    [Google Scholar]
  2. , , . Epidemiology of pediatric urolithiasis. Indian J Urol. 2010;26:516-22.
    [Google Scholar]
  3. , , , , . The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015;22:273-8.
    [Google Scholar]
  4. , , , , . Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010;157:132-7.
    [Google Scholar]
  5. , . Clinical analysis of upper urinary tract calculi in children of 286 patients. J Clin Urol. 2007;22:280-2.
    [Google Scholar]
  6. , , , , . Kidney stone recurrence among children and adolescents. J Urol. 2017;197:246-52.
    [Google Scholar]
  7. , , . Epidemiology of pediatric urolithiasis. Urinary tract stone disease 2010:409-20.
    [Google Scholar]
  8. , , , , . Use of ultrasound in pediatric renal stone diagnosis and surgery. Curr Urol Rep. 2017;18:22.
    [Google Scholar]
  9. , , , , , , . Pathophysiology-based treatment of urolithiasis. Int J Urol. 2017;24:32-8.
    [Google Scholar]
  10. , , , . Obesity and urolithiasis:Evidence of regional influences. Urolithiasis. 2017;45:271-8.
    [Google Scholar]
  11. , , , , . High incidence of urinary stones in uyghur children may be related to local environmental factors. J Pediatr Urol. 2014;10:289-93.
    [Google Scholar]
  12. , , , , , , . The association of increasing body mass index and kidney stone disease. J Urol. 2010;183:571-5.
    [Google Scholar]
  13. , , , , . Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population. Urolithiasis. 2014;42:379-85.
    [Google Scholar]
  14. , , . Gene expression and its role on urolithiasis. Clin Calcium. 2011;21:1473-9.
    [Google Scholar]
  15. , , , , , , . Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis. Ren Fail. 2016;38:378-82.
    [Google Scholar]
  16. , , , , . Correlation between ApoE gene polymorphisms and the occurrence of urolithiasis. Exp Ther Med. 2015;9:183-6.
    [Google Scholar]
  17. , , , , , , . Rapid and direct detection of apolipoprotein E genotypes using whole blood from humans. J Toxicol Environ Health A. 2010;73:1502-10.
    [Google Scholar]
  18. , , , . Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip. J Cardiovasc Dis Res. 2011;2:29-35.
    [Google Scholar]
  19. , , , , , , . Association of APOE, GCPII and MMP9 polymorphisms with common diseases and lipid levels in an older adult/elderly cohort. Gene. 2014;535:370-5.
    [Google Scholar]
  20. , , , , . Distribution of ApoE variants in four northeast distribution of apoe variants in four northeast Indian populations. Collegum Antropol. 2017;40:285-9.
    [Google Scholar]
  21. , , , , , . Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res. 1987;28:371-80.
    [Google Scholar]
  22. , , , , , , . Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population. Lipids Health Dis. 2016;15:34.
    [Google Scholar]
  23. , , , , , , . Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China. Lipids Health Dis. 2015;14:25.
    [Google Scholar]
  24. , , , , . Polymerase chain reaction amplification of a GC rich region by adding 1,2 propanediol. Adv Biomed Res. 2014;3:65.
    [Google Scholar]
  25. , , , , , . Genotyping of a patient homozygous for a rare apolipoprotein E1 [Gly127-Asp;Arg158-Cys] (Weisgraber allele) J Inherit Metab Dis. 1995;18:723-6.
    [Google Scholar]
  26. , , , , , , . Comparison of BMI, AHI, and apolipoprotein E ε4 (APOE-ε4) alleles among sleep apnea patients with different skeletal classifications. J Clin Sleep Med. 2014;10:397-402.
    [Google Scholar]
  27. , , , , , , . New insights into the distribution of APOE polymorphism in the Iberian Peninsula. The case of Andalusia (Spain) Ann Hum Biol. 2014;41:443-52.
    [Google Scholar]
  28. , , , , , , . Effect of CLU and PICALM polymorphisms on AD risk:A study from South India. Asian J Psychiatr. 2017;27:7-11.
    [Google Scholar]
  29. , , , , , , . Association between apolipoprotein E gene polymorphism and the dose for warfarin maintenance. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011;36:212-6.
    [Google Scholar]
  30. , , , , , , . The apolipoprotein E polymorphism:A comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49:338-49.
    [Google Scholar]
  31. , , , , , , . Association between APOE polymorphism and metabolic syndrome in Uyghur ethnic men. BMJ Open. 2016;6:e010049.
    [Google Scholar]
  32. , , , , . Analysis of genetical structure of the ancient xinjiang population. Chem Res Chin Univ. 2004;23:490-9.
    [Google Scholar]
  33. , . Ethnic amalgamation in the brim area of the tarim basin and the emerging and development of uygur nationality. Western Reg Studies. 2005;4:1-8, 110.
    [Google Scholar]
  34. , , , , , , . Apolipoprotein epsilon4 allele frequency in young Africans of Ugandan descent versus African Americans. J Natl Med Assoc. 2003;95:71-6.
    [Google Scholar]
  35. , , , , , , . Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. PLoS One. 2017;12:e0181620.
    [Google Scholar]
  36. , , , , , , . A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. J Clin Invest. 1984;73:1024-33.
    [Google Scholar]
Show Sections
Scroll to Top